INTERVIEW Star analyst-turned-CEO launches his own private equity firm
Aimbridge Founder and CEO Hwang Sang-youn / Courtesy of AimbridgeBy Anna J. ParkHwang Sang-youn is a trailblazer who has not hesitated to change his life's path during the last three decades of his career. His diverse work experiences as a stellar engineer, stock analyst, CFO and CEO led the 52-year to establish a private equity company of his own, Aimbridge LLC, earlier this year.He made the decision to open his own business shortly after resigning from his previous post as a head of the private equity business at Brain Asset Management late last year. Prior to the position, he served as CEO at Chong Kun Dang (CKD) Holdings, one of the major pharmaceutical companies in Korea, and as the CFO at MDimune, a bio-therapeutics venture firm. During his career path, constant challenges in new fields have expanded Hwang's realm of expertise. The bio and finance expert started his career as a chemistry researcher back in 1995, after receiving both bachelor's and master's degrees in chemistry from Seoul National University. After working as a researcher at LG Chem for five years, he decided to
